![Cannabinoids Reduce ErbB2-Driven Breast Cancer Progression Through Akt Inhibition]()
Published in Molecular Cancer, July 2010 Main Findings: THC-based medicine, when used as an experimental drug of treatment, significantly reduced breast cancer tumor growth, tumor numbers, induces cancer cell suicide (called apoptosis), and stopped the breast...
“Cannabidiol enhances the inhibitory effects of Delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival: The cannabinoid 1 (CB(1)) and cannabinoid 2 (CB(2)) receptor agonist Delta(9)-tetrahydrocannabinol (THC) has been shown to be a...
“Cannabinoids possess … anticancer activity [and may] possibly represent a new class of anti-cancer drugs that retard cancer growth, inhibit angiogenesis (the formation of new blood vessels) and the metastatic spreading of cancer cells.” So concludes a...
Gliomas (tumors in the brain) are especially aggressive malignant forms of cancer, often resulting in the death of affected patients within one to two years following diagnosis. There is no cure for gliomas and most available treatments provide only minor symptomatic...
![Cannabinoids Reduce ErbB2-Driven Breast Cancer Progression Through Akt Inhibition]()
Laboratory/Animal/Preclinical Studies Antitumor Effects Appetite Stimulation Analgesia Cannabinoids are a group of 21-carbon–containing terpenophenolic compounds produced uniquely by Cannabis sativa and Cannabis indica species.[1,2] These plant-derived compounds may...
